Commonwealth Equity Services’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Commonwealth Equity Services’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-508	Closed	-$16K	–	3922
2022 Q4	$16K	Sell	508 -12	-2%	-$875	﹤0.01%	3617
2022 Q3	$63K	Hold	520	–	–	﹤0.01%	3452
2022 Q2	$91K	Hold	520	–	–	﹤0.01%	3392
2022 Q1	$150K	Buy	520 +274	+111%	+$104K	﹤0.01%	3400
2021 Q4	$128K	Buy	+246	New	+$177K	﹤0.01%	3410

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Commonwealth Equity Services's BIOR Position: Q1 2023 in Review

Commonwealth Equity Services sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2023, closing a stake of 508 shares — an estimated $16K sold.

Commonwealth Equity Services first reported a position in BIOR in Q4 2021 and held it in 5 quarters. The position peaked at $150K in Q1 2022. 30 funds tracked by Wall St. Rank hold BIOR as of Q1 2023.

Commonwealth Equity Services reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Commonwealth Equity Services sold 508 Biora Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $16K.
Commonwealth Equity Services first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Commonwealth Equity Services's Biora Therapeutics, Inc. Common Stock position peaked at $150K in Q1 2022.
30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Commonwealth Equity Services's 13F filing for Q1 2023, filed 11 May 2023.